Anxiety and Related Sleep Disorders - Pakistan

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$34.35m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.45%, resulting in a market volume of US$35.13m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$3.11 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Pakistan is experiencing significant growth due to the rising prevalence of these conditions and increasing awareness about mental health in the country.

Customer preferences: Customers in Pakistan are increasingly seeking treatment for anxiety and related sleep disorders as they become more aware of the impact these conditions can have on their overall well-being. There is a growing demand for effective and accessible treatment options that can help manage symptoms and improve quality of life.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Pakistan is the increasing use of telemedicine and online platforms for consultations and treatment. This trend has been accelerated by the COVID-19 pandemic, which has limited in-person visits to healthcare facilities. Telemedicine provides a convenient and accessible way for individuals to seek help for their mental health concerns, especially in remote areas where access to specialized healthcare professionals may be limited.Another trend in the market is the growing preference for natural and holistic remedies for anxiety and sleep disorders. Many individuals in Pakistan are turning to alternative therapies such as herbal supplements, meditation, and yoga to manage their symptoms. This trend is driven by a desire for more personalized and natural approaches to healthcare.

Local special circumstances: Pakistan has a young population, with a significant portion of the population being under the age of 30. Younger generations are more open to discussing mental health and seeking help for anxiety and sleep disorders. This cultural shift is contributing to the growth of the market as more individuals are willing to acknowledge and address their mental health concerns.

Underlying macroeconomic factors: The overall economic development in Pakistan is also playing a role in the growth of the Anxiety and Related Sleep Disorders market. As the country experiences economic growth, there is an increase in disposable income and access to healthcare services. This allows individuals to afford and seek treatment for their mental health concerns.In conclusion, the Anxiety and Related Sleep Disorders market in Pakistan is witnessing significant growth due to the increasing awareness about mental health, the preference for accessible and holistic treatment options, and the overall economic development in the country. The use of telemedicine and online platforms for consultations is also contributing to the expansion of the market. As the understanding and acceptance of mental health continue to improve, it is expected that the market will continue to grow in the coming years.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.